SCHEMBL7400745

SCHEMBL7400745

COC(=O)C1=C(C)NC(C#N)=C(C(=O)OC)C1c1cc([N+](=O)[O-])ccc1OCCCCBr

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 3/20 0.55
AGTR1 P30556 2/20 0.55
SCN5A Q14524 2/20 0.55
NR1I2 O75469 1/20 0.55
NR3C1 P04150 1/20 0.55
ABCB1 P08183 1/20 0.55
TBXA2R P21731 1/20 0.55
CCKBR P32239 1/20 0.55
PTGS2 P35354 1/20 0.55
PDE4D Q08499 1/20 0.55
SLC29A1 Q99808 1/20 0.55
HIF1A Q16665 4/20 0.44
CACNA1C Q13936 4/20 0.44
CYP1A2 P05177 3/20 0.44
CYP3A4 P08684 3/20 0.44
CYP2C9 P11712 3/20 0.44
CYP2C19 P33261 3/20 0.44
KMT2A Q03164 3/20 0.44
MAPT P10636 3/20 0.44
MEN1 O00255 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7403809 0.94 ADORA3 (0.65) ADORA3AGTR1SCN5ANR1I2NR3C1
SCHEMBL9789920 0.92 ADORA3 (0.52) ADORA3AGTR1SCN5AHIF1ACACNA1C
SCHEMBL9485672 0.91 ADORA3 (0.53) ADORA3AGTR1SCN5ANR1I2NR3C1
SCHEMBL9483560 0.90 ADORA3 (0.44) ADORA3AGTR1SCN5ANR1I2NR3C1
SCHEMBL9483688 0.87 ADORA3 (0.66) ADORA3AGTR1SCN5ANR1I2NR3C1
SCHEMBL10692951 0.86 ADORA3 (0.53) ADORA3AGTR1SCN5AHIF1ACACNA1C
SCHEMBL7396515 0.85 ADORA3 (0.43) ADORA3AGTR1SCN5AHIF1ACACNA1C
SCHEMBL7403448 0.84 ADORA3 (0.43) ADORA3HIF1ACACNA1CCYP1A2CYP3A4
SCHEMBL10488355 0.83 ADORA3 (0.53) ADORA3AGTR1SCN5AHIF1ACACNA1C
SCHEMBL7287257 0.83 ADORA3 (0.53) ADORA3AGTR1SCN5AHIF1ACACNA1C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0741705-A1 4-(2-(3-ARYLOXY-2-HYDROXYPROPYLAMINO ALKYLOXY)-5-NITROPHENYL)-1,4-DIHYDROPYRIDINES AS ANTIHYPERTENSIVE AGENTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-11-13 EP disclosed
WO-1995020576-A1 4-(2-(3-ARYLOXY-2-HYDROXYPROPYLAMINO ALKYLOXY)-5-NITROPHENYL)-1,4-DIHYDROPYRIDINES AS ANTIHYPERTENSIVE AGENTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1995-08-03 WO disclosed